Formuepleje A/S’s Boston Scientific BSX Stock Holding History

Formuepleje A/S’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	26,036 -87,609	-77%	-$4.76M	0.09%	85
2026 Q1	$7.13M	Sell	113,645 -222,807	-66%	-$17.8M	0.65%	28
2025 Q4	$32.1M	Sell	336,452 -6,085	-2%	-$597K	1.92%	20
2025 Q3	$33.4M	Sell	342,537 -39,974	-10%	-$4.14M	1.89%	21
2025 Q2	$38.6M	Hold	382,511	–	–	2.2%	14
2025 Q1	$38.6M	Sell	382,511 -38,526	-9%	-$3.88M	2.2%	14
2024 Q4	$37.6M	Sell	421,037 -63,569	-13%	-$5.6M	2.03%	16
2024 Q3	$40.6M	Buy	484,606 +79,809	+20%	+$6.29M	2.08%	15
2024 Q2	$31.2M	Buy	404,797 +15,807	+4%	+$1.16M	1.72%	20
2024 Q1	$26.6M	Sell	388,990 -41,456	-10%	-$2.67M	1.51%	24
2023 Q4	$24.9M	Sell	430,446 -18,617	-4%	-$994K	1.76%	17
2023 Q3	$23.7M	Sell	449,063 -114,856	-20%	-$6.02M	2.2%	15
2023 Q2	$30.5M	Sell	563,919 -393,768	-41%	-$20.6M	2.66%	11
2023 Q1	$47.9M	Buy	957,687 +49,271	+5%	+$2.32M	3.51%	6
2022 Q4	$42M	Buy	908,416 +426,338	+88%	+$18.5M	3.54%	4
2022 Q3	$18.7M	Buy	482,078 +378,455	+365%	+$15.2M	1.52%	26
2022 Q2	$3.86M	Buy	+103,623	New	+$4.22M	0.24%	59

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Formuepleje A/S's BSX Position: Q2 2026 in Review

Formuepleje A/S reduced its Boston Scientific (BSX) stake by 77% in Q2 2026, selling an estimated $4.76M and leaving 26,036 shares worth $1.11M. The position accounts for 0.09% of the portfolio, ranked #85.

Formuepleje A/S first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $47.9M in Q1 2023. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Formuepleje A/S held 26,036 shares of Boston Scientific worth $1.11M as of Q2 2026.
Formuepleje A/S sold 87,609 Boston Scientific shares in Q2 2026, an estimated $4.76M.
Boston Scientific made up 0.09% of Formuepleje A/S's portfolio in Q2 2026, its #85 holding.
Formuepleje A/S first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
Formuepleje A/S's Boston Scientific position peaked at $47.9M in Q1 2023.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Formuepleje A/S's 13F filing for Q2 2026, filed 27 Aug 2026.